365 related articles for article (PubMed ID: 20146698)
1. The progression of pathology in Parkinson's disease.
Halliday GM; McCann H
Ann N Y Acad Sci; 2010 Jan; 1184():188-95. PubMed ID: 20146698
[TBL] [Abstract][Full Text] [Related]
2. The progression of pathology in longitudinally followed patients with Parkinson's disease.
Halliday G; Hely M; Reid W; Morris J
Acta Neuropathol; 2008 Apr; 115(4):409-15. PubMed ID: 18231798
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease dementia: what's in a Lewy body?
Burn DJ
J Neural Transm Suppl; 2006; (70):361-5. PubMed ID: 17017554
[TBL] [Abstract][Full Text] [Related]
5. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.
Kempster PA; O'Sullivan SS; Holton JL; Revesz T; Lees AJ
Brain; 2010 Jun; 133(Pt 6):1755-62. PubMed ID: 20371510
[TBL] [Abstract][Full Text] [Related]
6. Research in motion: the enigma of Parkinson's disease pathology spread.
Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
Li JY; Englund E; Widner H; Rehncrona S; Björklund A; Lindvall O; Brundin P
Mov Disord; 2010 Jun; 25(8):1091-6. PubMed ID: 20198645
[TBL] [Abstract][Full Text] [Related]
9. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
10. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
11. Intralaminar nuclei of the thalamus in Lewy body diseases.
Brooks D; Halliday GM
Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
[TBL] [Abstract][Full Text] [Related]
12. A clinico-pathological study of subtypes in Parkinson's disease.
Selikhova M; Williams DR; Kempster PA; Holton JL; Revesz T; Lees AJ
Brain; 2009 Nov; 132(Pt 11):2947-57. PubMed ID: 19759203
[TBL] [Abstract][Full Text] [Related]
13. Neuropathology of Lewy body disorders.
Kövari E; Horvath J; Bouras C
Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
15. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
[TBL] [Abstract][Full Text] [Related]
16. Ageing, neurodegeneration and Parkinson's disease.
Hindle JV
Age Ageing; 2010 Mar; 39(2):156-61. PubMed ID: 20051606
[TBL] [Abstract][Full Text] [Related]
17. Milestones in Parkinson's disease--clinical and pathologic features.
Halliday G; Lees A; Stern M
Mov Disord; 2011 May; 26(6):1015-21. PubMed ID: 21626546
[TBL] [Abstract][Full Text] [Related]
18. Fulminant Lewy body disease.
Momjian-Mayor I; Pizzolato GP; Burkhardt K; Landis T; Coeytaux A; Burkhard PR
Mov Disord; 2006 Oct; 21(10):1748-51. PubMed ID: 16830307
[TBL] [Abstract][Full Text] [Related]
19. A critical reappraisal of current staging of Lewy-related pathology in human brain.
Jellinger KA
Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
[TBL] [Abstract][Full Text] [Related]
20. A Drosophila model of Parkinson's disease.
Feany MB; Bender WW
Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
